We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Trade associations representing research-based drug firms in Canada have continued to call on the government to reverse a reported decline in R&D investment.
Amid plans to shave healthcare spending by EUR3.5bn (US$4.35bn) by
2008, the French government is to remove reimbursement on 350 drugs described as having "low levels of effectiveness."
BioSante Pharmaceuticals, Inc. (Amex:BPA) today announced that it has signed a Material Transfer and Option Agreement with an undisclosed European pharmaceutical company for an exclusive option to obtain an exclusive, worldwide license to use BioSante's calcium phosphate nanotechnology (CaP) in the development of a series of allergy products.
LAM Pharmaceutical, Corp. (OTC: LAMP; Frankfurt: LAM; Berlin: LAM), a biomedical company focused on the development and commercialization of novel wound healing and transdermal drug delivery systems, announced today that it received a regulatory approval to market and sell its patented and proprietary LAM IPM Wound Gel(TM) in the Republic of Panama.
Pfizer Inc.'s (PFE.N: Quote, Profile, Research) drug Aromasin has been approved in Europe for the treatment of early breast cancer in post-menopausal women following surgery, the world's biggest drug maker said on Tuesday.
South Africa's government claims to have exceeded its own targets for HIV/AIDS treatment, dispensing ARVs to 61,000 people in the first year of a national campaign.